3.8 Article

The PVT1-MYC duet in cancer

Journal

MOLECULAR & CELLULAR ONCOLOGY
Volume 2, Issue 2, Pages -

Publisher

TAYLOR & FRANCIS INC
DOI: 10.4161/23723556.2014.974467

Keywords

8q24.21; amplification; breast cancer; copy number gain; HCT116; MYC; MDA-MB-231; PVT1; SK-BR-3; TCGA

Categories

Funding

  1. Masonic Cancer Center Laboratory start-up funds
  2. Masonic Scholar Award
  3. Karen Wyckoff Rein in Sarcoma Fund
  4. Institute of Prostate and Urologic Cancer, University of Minnesota
  5. American Cancer Society Research Scholar Grant [RSG-14-074-01-TBG]

Ask authors/readers for more resources

Gain of 8q24, harboring the avian myelocytomatosis viral oncogene homolog (MYC), is a frequent mutation in cancers. Although MYC is the usual suspect in these cancers, the role of other co-gained loci remains mostly unknown. We have recently found that MYC partners with the adjacent long non-coding RNA (lncRNA) plasmacytoma variant translocation 1 (PVT1), which stabilizes MYC protein and potentiates its activity.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available